Vivimed Labs & Strides Shasun to form two JVs to tap US generic market

Vivimed Labs Ltd, a pharmaceuticals & specialty chemicals company, has signed agreements with Strides Shasun Ltd to set up two joint venture companies. The 50:50 JV in India will own Vivimed’s US FDA inspected finished dosage formulation (FDF) facility in Alathur (Chennai, Tamil Nadu), while the 50:50 JV in Singapore will own certain approved ANDAs and product pipeline.

Vivimed believes the JV partnership with Strides Shasun offers its portfolio of products the synergies from Strides Shasun’s existing front end in the US market. This coupled with Vivimed’s product development pipeline for the US offers the JV a strong opportunity to